澳洲优德煤业欧立安顿MDS项目获批在望

2014-12-19 07:50:00 来源：澳华财经在线 编辑：Jeff, Mark 文章类型：原创

澳大利亚优德煤业（ASX：UND）子公司Endocoal获得澳洲土地法院的推荐判令，欧立安顿MDS项目的开采许可申请MLA70452获批在望。

ACB News《澳华财经在线》报道，优德煤业18日公告，土地法院已向负责矿产资源法案的部长作出推荐，建议授予MLA70452号采矿租约。同时该租约将加入特殊条款，规定Endocoal应在获得项目许可授权后的12个月内或项目开采启动之前与矿区土地拥有者达成土地使用相关协议。

土地法院同时向环境保护法案部长建议通过MDS项目审批，尽快下发该项目的环境许可。

MLA70452申请的最后一步将是与矿区土地拥有者商定补偿事宜。相关调解会议将于2015年1月30日进行。若双方未就土地补偿达成一致，土地法院听证会将于3月16日召开。优德煤业预期明年上半年可获批采矿租约。

去年5月，优德煤业成功收购澳交所上市的煤炭勘探公司Endocoal，随后于今年2月在澳交所上市。公司在昆士兰州博恩盆地中北部拥有面积广阔的勘探地，资源量增长潜力巨大且便于集中联合开发，共拥有31个矿证，总勘探面积达5700平方公里，已探明JORC认证煤炭储量为5.5亿吨。

其中位于昆士兰中部小镇斯普林休尔（Springsure）东南45千米处的欧立安顿MDS项目是优德煤业最有潜力的近期开发项目。据可行性报告分析，MDS矿区JORC认证煤炭资源量为1682万吨，其中适销储量为1300万吨。该项目具有诸多突出优势，包括原煤灰分超低，无需洗煤；剥采比低，原煤含硫量非常低（开采及用户使用成本降低），原煤发热值高达6000大卡以上等。

（郑重声明：ACB News《澳华财经在线》对本文保留全部著作权限，转发时请标注来源）

Tags: UND 优德煤业

相关阅读

: 2025财年澳洲股票基金排行榜出炉前五名收益率均超20%

人力资源和投资咨询公司美世（Mercer）发布的2025财年澳洲股票基金回报率排行榜显示，Chester Opportunities Fund以25.4%的回报率荣登榜首，前5名的回报率均超过20%，其中4只为可持续基金。

: Bowen Coking Coal (ASX: BCB) Hits FY25 Output Target Early, Seeks Funding in Trading Halt

While The company confirmed it had achieved its full-year FY25 run-of-mine (ROM) coal production and sales guidance , Bowen’s share price declined sharply prior to the trading halt, closing at A$0.096 on 23June, with the company’s market capitalisation falling at about A$10 million — a sharp contrast to the hundreds of millions it was valued at during the COVID-era peak.

: US Market Watch | Dow Eyes 45,000 Amid Tentative June Rebound

Following a volatile correction earlier this year, US equities have staged a strong comeback since mid-April. The Dow, Nasdaq, and S&P 500 all posted impressive gains in May—among the best monthly performances in years.

: Adriatic Metals回应媒体收购传闻证实正与Dundee Precious Metals洽谈潜在收购事项

Adriatic Metals plc（LSE: ADT1；ASX: ADT）上周（5月21日）发布公告，证实公司正在与加拿大矿业公司Dundee Precious Metals Inc.进行初步洽谈，探讨后者可能对Adriatic发起收购的可能性。

: 【异动股】银矿生产商Adriatic Metals (ASX:ADT)回应媒体收购传闻股价大涨25%

Adriatic Metals Plc (ASX股票代码:ADT)股价异动，周三飙涨25.27%。澳华财经在线数据库显示，ADT最新价4.71澳元，已发行股本3.45亿股，市值16.3亿澳元。截止一季度末公司账面现金结余7592万美元。

: Zip Co (ASX: ZIP) Rebounds Sharply — Is the Momentum Sustainable?

Zip Co Limited (ASX: ZIP) shares have staged a strong rebound, driven by improved financial performance and renewed investor interest. The stock remains high-beta and volatile, with market attention focusing on its turnaround potential.

: ImpediMed (ASX: IPD) Reports Record Q3 Performance; Commercial Momentum Builds and Shares Rebound

5 May 2025 | ACB News – Sydney，ImpediMed Limited (ASX: IPD), a leading Australian medical technology company, has reported record results for the third quarter of FY2025, ended 31 March. Key financial metrics reached new highs as the company continues to scale deployment of its SOZO® digital health platform in the U.S.

: ImpediMed (ASX: IPD) Delivers Record Q3 Results; Shares Rebound Last Week with Increasing Trading Volume

ImpediMed Limited (ASX: IPD) has reported record financial results for Q3 FY25, with revenue reaching A$3.4 million (+28% YoY), cash receipts at A$4.1 million, and ARR rising to A$13.7 million (+27% YoY). Total Contracted Value (TCV) hit A$4.9 million, up 53% from the previous quarter.

免责声明：本网所发所有文章，包括本网原创、编译及转发的第三方稿件及评论，均不构成任何投资建议，交易操作或投资决定请询问专业人士。